Management of chronic kidney disease: The current novel and forgotten therapies

Area of Science:

• Nephrology
• Public Health
• Gerontology

Background:

• Chronic kidney disease (CKD) is a progressive, incurable condition impacting global health, particularly aging populations.
• Estimated to affect over 800 million people worldwide, CKD poses a significant health burden.
• Individuals with diabetes or hypertension face elevated risks of developing chronic kidney damage.

Purpose of the Study:

• To provide a narrative review of current therapeutic options for slowing the progression of chronic kidney disease (CKD).
• To highlight recent advancements in drug treatments and their impact on CKD management.
• To emphasize the critical importance of disease prevention and the need for further research in CKD.

Main Methods:

• A comprehensive literature search was conducted to identify relevant studies on CKD treatments.
• Narrative review methodology was employed to synthesize findings on therapeutic strategies.
• Focus was placed on summarizing available treatments and recent drug developments.

Main Results:

• Several new drug treatments have become available, offering new hope for CKD management.
• Dietary modifications and existing medications remain important for slowing disease progression.
• Early diagnosis is crucial for preventing complications associated with CKD.

Conclusions:

• While new treatments are promising, disease prevention remains the most critical aspect of CKD management.
• Significant public health impact necessitates further research into more effective diagnostic tools and treatments for CKD.
• Advancements in technology and medical knowledge are expected to improve future CKD care.